(1)
Clinical Outcomes of a Treat-and-Extend Regimen With Intravitreal Aflibercept Injections in Patients With Choroidal Neovascularization Secondary to Chronic Central Serous Chorioretinopathy. Ukr. j. ophthalmol. 2024, No. 4, 46-51. https://doi.org/10.31288/oftalmolzh202444651.